These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 32205482)
1. Endometrial Carcinomas with a "Serous" Component in Young Women Are Enriched for DNA Mismatch Repair Deficiency, Lynch Syndrome, and POLE Exonuclease Domain Mutations. Conlon N; Da Cruz Paula A; Ashley CW; Segura S; De Brot L; da Silva EM; Soslow RA; Weigelt B; DeLair DF Am J Surg Pathol; 2020 May; 44(5):641-648. PubMed ID: 32205482 [TBL] [Abstract][Full Text] [Related]
2. Molecularly Classified Uterine FIGO Grade 3 Endometrioid Carcinomas Show Distinctive Clinical Outcomes But Overlapping Morphologic Features. Joehlin-Price A; Van Ziffle J; Hills NK; Ladwig N; Rabban JT; Garg K Am J Surg Pathol; 2021 Mar; 45(3):421-429. PubMed ID: 33021522 [TBL] [Abstract][Full Text] [Related]
3. Analysis of 108 patients with endometrial carcinoma using the PROMISE classification and additional genetic analyses for MMR-D. Timmerman S; Van Rompuy AS; Van Gorp T; Vanden Bempt I; Brems H; Van Nieuwenhuysen E; Han SN; Neven P; Victoor J; Laenen A; Vergote I Gynecol Oncol; 2020 Apr; 157(1):245-251. PubMed ID: 31980219 [TBL] [Abstract][Full Text] [Related]
8. Molecular Analysis of Mixed Endometrial Carcinomas Shows Clonality in Most Cases. Köbel M; Meng B; Hoang LN; Almadani N; Li X; Soslow RA; Gilks CB; Lee CH Am J Surg Pathol; 2016 Feb; 40(2):166-180. PubMed ID: 26492180 [TBL] [Abstract][Full Text] [Related]
9. Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer. Mills AM; Liou S; Ford JM; Berek JS; Pai RK; Longacre TA Am J Surg Pathol; 2014 Nov; 38(11):1501-9. PubMed ID: 25229768 [TBL] [Abstract][Full Text] [Related]
10. Blinded histopathological characterisation of POLE exonuclease domain-mutant endometrial cancers: sheep in wolf's clothing. Van Gool IC; Ubachs JEH; Stelloo E; de Kroon CD; Goeman JJ; Smit VTHBM; Creutzberg CL; Bosse T Histopathology; 2018 Jan; 72(2):248-258. PubMed ID: 28795426 [TBL] [Abstract][Full Text] [Related]
11. POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium. Meng B; Hoang LN; McIntyre JB; Duggan MA; Nelson GS; Lee CH; Köbel M Gynecol Oncol; 2014 Jul; 134(1):15-9. PubMed ID: 24844595 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic analysis of matched primary and recurrent endometrial carcinoma. Soslow RA; Wethington SL; Cesari M; Chiappetta D; Olvera N; Shia J; Levine DA Am J Surg Pathol; 2012 Dec; 36(12):1771-81. PubMed ID: 23154767 [TBL] [Abstract][Full Text] [Related]
13. Utility of a custom designed next generation DNA sequencing gene panel to molecularly classify endometrial cancers according to The Cancer Genome Atlas subgroups. Miller EM; Patterson NE; Gressel GM; Karabakhtsian RG; Bejerano-Sagie M; Ravi N; Maslov A; Quispe-Tintaya W; Wang T; Lin J; Smith HO; Goldberg GL; Kuo DYS; Montagna C BMC Med Genomics; 2020 Nov; 13(1):179. PubMed ID: 33256706 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and molecular characterization of high-grade endometrial carcinoma with POLE mutation: a single center study. Yu S; Sun Z; Zong L; Yan J; Yu M; Chen J; Lu Z J Gynecol Oncol; 2022 May; 33(3):e38. PubMed ID: 35320887 [TBL] [Abstract][Full Text] [Related]
16. Polymerase Epsilon Exonuclease Domain Mutations in Ovarian Endometrioid Carcinoma. Hoang LN; McConechy MK; Köbel M; Anglesio M; Senz J; Maassen M; Kommoss S; Meng B; Postovit L; Kelemen LE; Staebler A; Brucker S; Krämer B; McAlpine JN; Gilks CB; Huntsman DG; Lee CH Int J Gynecol Cancer; 2015 Sep; 25(7):1187-93. PubMed ID: 26166557 [TBL] [Abstract][Full Text] [Related]
17. Molecular Profiles of Mixed Endometrial Carcinoma. Matrai C; Motanagh S; Mirabelli S; Ma L; He B; Chapman-Davis E; Kurtis B; Elemento O; Mosquera JM; Ellenson LH Am J Surg Pathol; 2020 Aug; 44(8):1104-1111. PubMed ID: 32604171 [TBL] [Abstract][Full Text] [Related]
18. Germline MLH1 Mutations Are Frequently Identified in Lynch Syndrome Patients With Colorectal and Endometrial Carcinoma Demonstrating Isolated Loss of PMS2 Immunohistochemical Expression. Dudley B; Brand RE; Thull D; Bahary N; Nikiforova MN; Pai RK Am J Surg Pathol; 2015 Aug; 39(8):1114-20. PubMed ID: 25871621 [TBL] [Abstract][Full Text] [Related]
19. Dedifferentiated endometrial carcinomas with neuroendocrine features: a clinicopathologic, immunohistochemical, and molecular genetic study. Espinosa I; De Leo A; D'Angelo E; Rosa-Rosa JM; Corominas M; Gonzalez A; Palacios J; Prat J Hum Pathol; 2018 Feb; 72():100-106. PubMed ID: 29133142 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathological analysis of endometrial carcinomas harboring somatic POLE exonuclease domain mutations. Hussein YR; Weigelt B; Levine DA; Schoolmeester JK; Dao LN; Balzer BL; Liles G; Karlan B; Köbel M; Lee CH; Soslow RA Mod Pathol; 2015 Apr; 28(4):505-14. PubMed ID: 25394778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]